Document Detail


Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation.
MedLine Citation:
PMID:  8585483     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To evaluate efficacy and clinical benefit of early thrombolytic therapy in intracranial internal carotid artery occlusion. METHODS: Thirty-two patients (mean age, 56 years) with acute intracranial internal carotid artery occlusion were studied clinically and with CT and angiography before and after thrombolytic therapy with intravenous alteplase (n = 16), superselective intraarterial alteplase (n = 8), and superselective intraarterial urokinase (n = 8). RESULTS: Initial CT showed a large parenchymal hypodensity in 11 (34%) patients, a small hypodensity in 15 (47%) patients, and no hypodensity in 6 (19%) patients. Recanalization after thrombolytic therapy was observed in 4 patients (12.5% in each treatment group). Follow-up CT showed six hemorrhagic infarcts and four parenchymal hematomas unrelated to recanalization, alteplase, or urokinase administration, but commonly associated with intraarterial treatment. Clinical outcome was fatal in 53%, poor in 31%, and moderate or good in 16% of the patients. Outcome was equal in different treatment groups and closely linked to both the quality of leptomeningeal collaterals and the extent of parenchymal hypodensity on the first CT. CONCLUSION: Because intravenous or intraarterial treatment with alteplase or urokinase fails to recanalize the vascular obstruction, it does not improve the prognosis of intracranial internal carotid artery occlusion over that of the natural course. Improved results may be possible with novel recanalization techniques.
Authors:
O Jansen; R von Kummer; M Forsting; W Hacke; K Sartor
Related Documents :
16307933 - Carotid artery stenting with neuroprotection: assessing the learning curve and treatmen...
20705933 - Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incid...
21700113 - Recurrent enterococcal endophthalmitis seeded by an intraocular lens biofilm.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  AJNR. American journal of neuroradiology     Volume:  16     ISSN:  0195-6108     ISO Abbreviation:  AJNR Am J Neuroradiol     Publication Date:    1995 Nov-Dec
Date Detail:
Created Date:  1996-03-21     Completed Date:  1996-03-21     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  8003708     Medline TA:  AJNR Am J Neuroradiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1977-86     Citation Subset:  IM    
Affiliation:
Department of Neuroradiology, University of Heidelberg, School of Medicine, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Brain Ischemia / drug therapy,  mortality,  radiography
Carotid Artery Thrombosis / drug therapy*,  mortality,  radiography
Carotid Artery, Internal / drug effects,  radiography
Cerebral Infarction / drug therapy,  mortality,  radiography
Collateral Circulation / drug effects,  physiology
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Fibrinolytic Agents / adverse effects,  therapeutic use*
Humans
Intracranial Embolism and Thrombosis / drug therapy*,  mortality,  radiography
Male
Meninges / blood supply
Middle Aged
Survival Rate
Thrombolytic Therapy*
Tissue Plasminogen Activator / adverse effects,  therapeutic use*
Treatment Outcome
Urokinase-Type Plasminogen Activator / adverse effects,  therapeutic use*
Chemical
Reg. No./Substance:
0/Fibrinolytic Agents; EC 3.4.21.68/Tissue Plasminogen Activator; EC 3.4.21.73/Urokinase-Type Plasminogen Activator
Comments/Corrections
Comment In:
AJNR Am J Neuroradiol. 1995 Nov-Dec;16(10):1994-2000   [PMID:  8585485 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Experimental arteriovenous fistulas: treatment with porous metallic stents.
Next Document:  Cost-effectiveness of emergency intraarterial intracerebral thrombolysis: a pilot study.